H. Valerio

发表

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.

M. Alavi, G. Dore, L. Degenhardt, 2021, The International journal on drug policy.

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.

M. Alavi, P. Read, A. Milat, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.

H. Innes, S. Hutchinson, D. Goldberg, 2018, The International journal on drug policy.

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

S. Hutchinson, M. Hickman, N. Martin, 2016, Journal of viral hepatitis.

Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.

M. Alavi, G. Dore, M. Law, 2019, Journal of hepatology.

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.

P. Hayes, H. Innes, S. Hutchinson, 2017, Journal of hepatology.

The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort‐study

M. Alavi, H. Innes, S. Hutchinson, 2018, Hepatology.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study

M. Alavi, P. Hayes, G. Dore, 2018, Journal of viral hepatitis.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison

M. Alavi, P. Hayes, G. Dore, 2017 .

Inpatient hospital burden of hepatitis C‐diagnosed patients with decompensated cirrhosis

M. Alavi, P. Hayes, H. Innes, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect‐acting antiviral era

M. Alavi, P. Hayes, H. Innes, 2017, Journal of viral hepatitis.

Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis.

G. Dore, J. Grebely, B. Hajarizadeh, 2020, The Journal of infectious diseases.

Opportunities to enhance linkage to hepatitis C care among hospitalised people with recent drug dependence in New South Wales, Australia: A population-based linkage study.

M. Alavi, G. Dore, M. Law, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales

M. Alavi, G. Dore, J. Amin, 2022, JHEP reports : innovation in hepatology.

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.

H. Innes, S. Hutchinson, J. Dillon, 2015, The International journal on drug policy.

Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis‐related mortality – results from two surveys (2016)

L. Tavoschi, T. Noori, H. Valerio, 2018, HIV medicine.

Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment.

M. Alavi, V. Wiseman, G. Dore, 2022, Drug and alcohol dependence.

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications

Jisoo A. Kwon, M. Alavi, R. Guy, 2021, PloS one.

Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.

J. Lewsey, P. Hayes, H. Innes, 2015, Drug and alcohol dependence.

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.

M. Alavi, P. Hayes, G. Dore, 2017, Journal of hepatology.

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

P. Hayes, H. Innes, S. Hutchinson, 2020, Gut.

Factors associated with spontaneous clearance of chronic hepatitis C virus infection.

H. Innes, A. Stanley, R. Gunson, 2016, Journal of hepatology.

FACTORS ASSOCIATED WITH SPONTANEOUS CLEARANCE OF CHRONIC 1 HEPATITIS C VIRUS INFECTION : A RETROSPECTIVE CASE CONTROL 2 STUDY 3

H. Innes, A. Stanley, R. Gunson, 2016 .

Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

P. Read, G. Dore, J. Grebely, 2022, Viruses.

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study

M. Alavi, P. Read, A. Milat, 2022, Viruses.

Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study

M. Alavi, G. Dore, M. Martinello, 2022, Journal of viral hepatitis.

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.

G. Dore, M. Law, M. Hickman, 2019, Journal of hepatology.

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis.

P. Read, G. Dore, P. Vickerman, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.

P. Hayes, H. Innes, S. Hutchinson, 2016, Drug and alcohol dependence.

Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population.

P. Hayes, H. Innes, S. Hutchinson, 2017, Journal of hepatology.

The contribution of alcohol-use disorder to decompensated cirrhosis among people with hepatitis C: an international comparison study

M. Alavi, P. Hayes, G. Dore, 2017 .

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia

M. Alavi, G. Dore, J. Grebely, 2022, Viruses.

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study

G. Dore, J. Stone, A. Lim, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.

M. Alavi, P. Read, G. Dore, 2022, The International journal on drug policy.

Creating an environment for equitable access to direct‐acting antiviral therapy for people who inject drugs with hepatitis C

G. Dore, J. Grebely, H. Valerio, 2020, Liver international (Print).

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.

M. Alavi, P. Read, A. Milat, 2022, The International journal on drug policy.

Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis

Jisoo A. Kwon, V. Wiseman, G. Dore, 2023, Social Science Research Network.

Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis

P. Hayes, H. Innes, S. Hutchinson, 2018 .

Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

P. Hayes, H. Innes, S. Hutchinson, 2017 .

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes

H. Innes, S. Hutchinson, D. Wilks, 2015, Hepatology.

Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study.

M. Alavi, G. Dore, J. Amin, 2023, Drug and alcohol review.

M. Alavi, G. Dore, B. Hajarizadeh, 2023, Journal of viral hepatitis.

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis

P. Hayes, Huan Wang, H. Innes, 2018, Journal of viral hepatitis.

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia.

M. Alavi, G. Dore, M. Law, 2020, Journal of hepatology.

Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study.

P. Read, G. Dore, L. Degenhardt, 2023, Drug and alcohol review.

Cascade of care among people with hepatitis B in New South Wales, Australia.

M. Alavi, G. Dore, B. Hajarizadeh, 2023, Journal of viral hepatitis.

Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study

M. Alavi, G. Dore, J. Grebely, 2022, Journal of viral hepatitis.

Opportunities to enhance linkage to hepatitis C care among people hospitalised for injection drug use-related complications: a population-based study

M. Alavi, G. Dore, J. Amin, 2020, Journal of Hepatology.

Edinburgh Research Explorer Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C

M. Alavi, G. Dore, H. Innes, 2017 .

Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection.

H. Innes, S. Hutchinson, A. Stanley, 2015, Drug and alcohol dependence.